TwoFour Insight (@TwoFourInsight) header
TwoFour Insight (@TwoFourInsight) profile picture

Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets ≠ endorsement

Pitt | WashDC | New Delhi
Joined January 2014
Allergan ($AGN) & Pfizer ($PFE) Notify Merger Details to Competition Commission of #India … buff.ly/1OlnMlX
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation ($GILD) #India #pharma buff.ly/1OH7GgF
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1JosuIi
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1Josic2
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation ($GILD) #India #pharma buff.ly/1Yx2EIR
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1OGeZW3
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1S4O1Nc
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation - TwoFour Insight Group buff.ly/1Yx1jSo
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1YrqMSF
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1RAkviZ